BPC-157
Also: BPC 157, PL 14736, body protection compound-157
A synthetic pentadecapeptide (15 amino acids) derived from a fragment of human gastric juice protein, studied in animal models for effects on tissue repair, angiogenesis, and gastrointestinal healing. It has no completed human randomized controlled trials and is not FDA-approved for any use; FDA's Pharmacy Compounding Advisory Committee gave it a favorable recommendation for compounding eligibility in July 2026.